![](/img/cover-not-exists.png)
267P Irinotecan monotherapy as third line treatment for advanced gastric cancer patients refractory fluoropyrimidine, platinum and taxanes harboring UGT1A1*1/*1. *1/*6 or *1/*28
Sugimoto, N., Yoshinami, T., Yagi, T., Hasegawa, A., Fujisawa, F., Imamura, F.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw582.048
Date:
December, 2016
File:
PDF, 70 KB
2016